Abstract
Background A 62-year-old white woman was admitted to hospital with a 2-month history of progressive, painless, left supraclavicular and axillary lymph node enlargement. The patient's history was significant for chronic HCV infection, for which she had just completed a 48-week course of treatment with pegylated interferon α (180 µg once weekly) plus ribavirin (1,000 mg daily). She attained an end-of-treatment response and subsequent qualitative measurement of HCV RNA confirmed a sustained virological response. The onset of progressive painless lymph node enlargement had been noted by the patient during the last 2 weeks of her treatment for HCV.
Investigations Physical examination, otorhinolaryngological examination, laboratory investigations (including complete blood counts, liver function tests and serological tests), mammography, thyroid and abdominal ultrasound, CT scans, abdominal MRI, upper gastrointestinal endoscopy, colonoscopy, supraclavicular lymph node biopsy, 67Ga scintigraphy and bronchoalveolar lavage.
Diagnosis Granulomatous lymphadenitis of uncertain etiology with sarcoid-type and tuberculoid-type granulomas.
Management Standard antituberculosis treatment with isoniazid, rifampicin, pyrazinamide and ethambutol for 2 months, followed by isoniazid and rifampicin for 7 months.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cervin JR et al. (1995) Virchow's node revisited. Analysis with clinicopathologic correlation of 152 fine-needle aspiration biopsies of supraclavicular lymph nodes. Arch Pathol Lab Med 119: 727–730
ATS/ERS/WASOG Committee (1999) Statement on Sarcoidosis. Am J Respir Crit Care Med 160: 736–755
Alazemi S and Campos MA (2006) Interferon-induced sarcoidosis. Int J Clin Pract 60: 201–211
Pietropaoli A et al. (1999) Interferon-alpha therapy associated with the development of sarcoidosis. Chest 116: 569–572
Teragawa H et al. (1996) Sarcoidosis after interferon therapy for chronic active hepatitis C. Intern Med 35: 19–23
Tahan V et al. (2003) Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature. Dig Dis Sci 48: 169–173
Goldberg HJ et al. (2006) Sarcoidosis after treatment with interferon-alpha: a case series and review of the literature. Respir Med 100: 2063–2068
Hoffmann RM et al. (1998) Sarcoidosis associated with interferon-(alpha) therapy for chronic hepatitis C. J Hepatol 28: 1058–1063
Bonnet F et al. (2002) Sarcoidosis-associated hepatitis C virus infection. Dig Dis Sci 47: 794–796
Johns CJ and Michele TM (1999) The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine 78: 65–111
Harry LI (1994) Sarcoidosis lymphadenopathy. I. Lymph node pathology, edn 2, Chapter 30 206–216 Philadelphia: JB Lippincott Company
Furin JJ and Johnson JL (2005) Recent advances in the diagnosis and management of tuberculosis. Curr Opin Pulm Med 11: 189–194
Jha BC et al. (2001) Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management. Postgrad Med J 77: 185–187
Portuguese National Program against Tuberculosis (2005) [Portuguese] [http://www.dgsaude.pt/upload/membro.id/ficheiros/i006875.pdf] (accessed 5 May 2008)
American Thoracic Society; Centers for Disease Control and Prevention; and Infectious Diseases Society of America (2003) Treatment of Tuberculosis. Am J Respir Crit Care Med 167: 603–662
Acknowledgements
We would like to thank Professor R Marinho and Dr C Baldaia for their helpful suggestions during the drafting of the article and also for their words of encouragement.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ferreira, C., Barjas, E., Correia, L. et al. Generalized peripheral lymphadenopathy in a patient treated for chronic HCV infection. Nat Rev Gastroenterol Hepatol 5, 469–474 (2008). https://doi.org/10.1038/ncpgasthep1176
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep1176